ALLR
BULLISH, It's supper undervalued. $19-$20 cash on hand, 1 million float, 1.4 million O/S, The company confirmed there will be zero need to dilute via ATM offering. They recently got granted EPO patent, FDA news should be out very soon.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
2 gaps need to filled on the way up, keep an eye on it. with $19-$20 million cash on hand, a price target of $10 is fairly valued even without FDA granted.
Declinazione di responsabilità
Le informazioni ed i contenuti pubblicati non costituiscono in alcun modo una sollecitazione ad investire o ad operare nei mercati finanziari. Non sono inoltre fornite o supportate da TradingView. Maggiori dettagli nelle Condizioni d'uso.